Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
Athol U. Wells(St Thomas' Hospital), Daniel F. Dilling, Е. Д. Баздырев, Manuel Quaresma(Royal Brompton & Harefield NHS Foundation Trust), С. Н. Авдеев, Gerard J. Criner(Temple University Hospital), E. James Britt, Kevin R. Flaherty(University of Michigan), Vincent Cottin(Université Claude Bernard Lyon 1), Luca Richeldi(Coral Reef Alliance), Adam Barczyk, Caroline Dahlqvist(Boehringer Ingelheim (United States)), Nazia Chaudhuri(University of Ulster), Nitin Bhatt, Anand Devaraj(Royal Brompton & Harefield NHS Foundation Trust), Rebecca Bascom, Benjamin Bondue(Université Libre de Bruxelles), Kevin K. Brown(Health Protection Surveillance Centre), Francesco Bonella(Ruhrlandklinik), Ketan Buch(St. Joseph’s Healthcare Hamilton), Paul Beirne(St. Joseph’s Healthcare Hamilton), André M. Cantin, Rainer-Georg Goeldner(Boehringer Ingelheim (Germany)), Miguel Bergna(St. Joseph’s Healthcare Hamilton), Agustina Díaz Cazaux, Myriam Aburto(St. Joseph’s Healthcare Hamilton), Shuichi Abe(Yamagata Prefectural Central Hospital), Stefan Blaas, Stefania Cerri(University of Modena and Reggio Emilia), Sonye K. Danoff(Johns Hopkins University), Bruno Crestani(Inserm), Said Chaaban, J. Dematte D'Amico(Royal Brompton & Harefield NHS Foundation Trust), Orlando Acosta, Rozsa Schlenker‐Herceg(Boehringer Ingelheim (United States)), Wim Wuyts(Universitair Ziekenhuis Leuven), Teng Moua(Mayo Clinic in Florida), Charles Andrews(Boehringer Ingelheim (United States)), Susanne Stowasser(Royal Brompton & Harefield NHS Foundation Trust), Hourong Cai(Boehringer Ingelheim (United States)), Martin Kolb(McMaster University), Emmanuel Bergot, German Arce, Elizabeth A. Belloli, John R. Burk(Royal Brompton & Harefield NHS Foundation Trust), Yoshikazu Inoue(Fukujuji Hospital), Manuel Arias(St. Joseph’s Healthcare Hamilton), Danielle Antin‐Ozerkis
Cited by 558
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k